.While the biotech assets performance in Europe has decreased rather following a COVID-19 financing ...
.After increasing $213 million in 2023-- some of the year's most extensive personal biotech shots-- ...
.Invite to recently's Chutes & Ladders, our summary of considerable leadership hirings, firings a...
.Financial backing funding in to biopharma cheered $9.2 billion around 215 deals in the second quart...
.Bicara Therapies and Zenas Biopharma have actually provided new inspiration to the IPO market with ...
.Genentech is going to close its cancer immunology investigation division, as well as device head an...
.Kezar Life Sciences is dropping its unpromising stage 1 strong lump medicine as the biotech goes al...
.In spite of izokibep preserving its newly found winning touch in the center, Acelyrin is no longer ...
.Rivus Pharmaceuticals has actually plumped up the potential customers of its fat-busting, muscle-sp...
.Ovid Therapeutics presently uncovered last month that it was trimming its head count as the company...